Document Detail

Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers.
MedLine Citation:
PMID:  23292866     Owner:  NLM     Status:  In-Data-Review    
Aberrant miR-199a-3p expression has been reported in several cancers. However, the clinical significance of miR-199a-3p in human colorectal cancer has not been addressed. In this study, we detected miR-199a-3p expression in 92 colorectal cancer cases to evaluate its clinicopathologic characteristics in colorectal cancer. We showed that miR-199a-3p expression was significantly upregulated in cancer tissues than NATs. Clinicopathologic analysis revealed that high miR-199a-3p expression contributed to more advanced lymphatic invasion, lymph node metastasis, liver metastases and late TNM stage in colorectal cancer. Kaplan-Meier analysis showed that high expression of miR-199a-3p could lead to a significantly shorter overall survival rate. Cox's proportional hazards model also indicated that the high expression of miR-199a-3p could serve as an independent and significant prognostic factor for survival. We transfected miR-199a-3p inhibitor into SW480 cells and observed that miR-199a-3p inhibitor could markedly inhibit the cell proliferation. Flow cytometry analysis also found that miR-199a-3p inhibitor could cause G0/G1 arrest, decreased percentage of S and G2/M phase and induce more cell apoptosis in SW480 cells. These results suggested that miR-199a-3p may serve as an efficient biomarker for diagnosis and novel prognostic indicator in colorectal cancer.
Daiwei Wan; Songbing He; Binhui Xie; Guohui Xu; Wen Gu; Chenglong Shen; You Hu; Xinsheng Wang; Qiaoming Zhi; Liang Wang
Related Documents :
18336196 - Modulation of trail-induced apoptosis by hdac inhibitors.
25068616 - Improving the anticancer activity of curcumin using nanocurcumin dispersion in water.
25119466 - Anticancer activities of pterostilbene-isothiocyanate conjugate in breast cancer cells:...
21520156 - Brca1 mutations do not increase prostate cancer risk: results from a meta-analysis incl...
15800936 - Bm18: a novel androgen-dependent human prostate cancer xenograft model derived from a b...
16301026 - The learning curve for emr with circumferential mucosal incision in treating intramucos...
Publication Detail:
Type:  Journal Article     Date:  2013-01-06
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  30     ISSN:  1559-131X     ISO Abbreviation:  Med. Oncol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-01-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  378     Citation Subset:  IM    
Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma.
Next Document:  New progress of non-surgical treatments for hepatocellular carcinoma.